Home | Structured Search | Drug Resource
Find: within
West Nile Virus Disease > Screening Author: Amy V. Bode, MD, MSPH; James J. Sejvar, MD; Anthony A. Marfin, MD, MPH
Editorial changes - 2008-07-29
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Viremic persons may be asymptomatic, and the virus can be transmitted through blood products.

Evidence:

  • In an investigation of 60 cases of WNV illness in blood product recipients, 23 had evidence of contracting the virus through transfusion (18).
  • More than 1000 potentially viremic donations have been screened out by national blood donor screening programs. Approximately 5% to 10% of infectious donations may be missed by mini-pool screening. To minimize the risk of transmission, blood centers may switch to single-unit screening in areas with ongoing transmission to humans. All 30 known cases of transfusion-transmitted WNV have resulted from IgM-negative donations (19).

Comments:

  • As of March 2006, seven cases of transfusion-associated WNV transmission from screened blood had been reported. In all instances, the currently employed mini-pool screening format used by the blood banks failed to identify the infectious donor (20). Physicians should continue to report transfusion recipients who subsequently develop WNV illness to their state or local public health departments.

FAQs
Amy V. Bode, MD, MSPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Anthony A. Marfin, MD, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Carrie Nielsen, PhD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. James J. Sejvar, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.